Dermatology · Tulsa, OK
NPI
1598760712
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9245 S Mingo Rd, Suite 335
Tulsa, OK, 74133
Phone (918) 492-8980
Groups this clinician bills Medicare through
Medicare paid, 2024
$178K
3,253 services
Medicare patients, 2024
1,087
Average age 75
Drug cost, 2024
$1.5M
1,974 prescriptions
Company payments, 2025
$3,434
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bernard N Robinowitz was code 99213 (office e&m - established), 1,305 times for 792 patients. In total Bernard N Robinowitz billed 3,253 services in 45 codes, and Medicare paid $178K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,305 | 792 | $55.56 | $73K |
| 17003 Destruction Skin Lesion | Office | 401 | 147 | $4.39 | $1,762 |
| 17000 Destruction Skin Lesion | Office | 290 | 237 | $39.59 | $11K |
| 99203 Office E&M - New | Office | 255 | 255 | $68.09 | $17K |
| 17110 Destruction Skin Lesion | Office | 241 | 197 | $70.80 | $17K |
| 99214 Office E&M - Established | Office | 218 | 156 | $79.47 | $17K |
| 11102 Skin Biopsy | Office | 110 | 106 | $54.06 | $5,947 |
| 11106 Skin Biopsy | Office | 58 | 57 | $107.53 | $6,237 |
| 96372 Injection Administration | Office | 43 | 13 | $9.73 | $418 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 28 | 11 | $0.76 | $21.16 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 27 | 25 | $283.74 | $7,661 |
| 99204 Office E&M - New | Office | 23 | 23 | $110.77 | $2,548 |
| 96574 Skin | Office | 21 | 19 | $195.75 | $4,111 |
| 11103 Skin Biopsy | Office | 21 | 19 | $30.11 | $632 |
| 17262 Destruction Skin Lesion | Office | 17 | 13 | $106.42 | $1,809 |
By year: 2022 $185K for 3,131 services; 2023 $193K for 3,388 services; 2024 $178K for 3,253 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bernard N Robinowitz prescribed most often to Medicare patients was Fluconazole, with 215 prescriptions and refills. In total Bernard N Robinowitz wrote 1,974 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluconazole Generic | 215 | 462 | 93 | $2,180 |
| Triamcinolone Acetonide Generic | 175 | 206 | 103 | $3,009 |
| Ketoconazole Generic | 110 | 112 | 62 | $1,795 |
| Doxepin Hcl Generic | 98 | 128 | 34 | $1,072 |
| Minocycline Hcl Generic | 83 | 140 | 27 | $1,994 |
| Acitretin Generic | 82 | 122 | 21 | $29K |
| Doxycycline Hyclate Generic | 81 | 130 | 34 | $1,769 |
| Hydroxyzine Hcl Generic | 79 | 85 | 23 | $1,113 |
| Amitriptyline Hcl Generic | 77 | 113 | 29 | $641 |
| Otezla Apremilast | 77 | 77 | 11 | $377K |
| Valacyclovir Valacyclovir Hcl | 59 | 89 | 18 | $1,491 |
| Fluocinonide Generic | 56 | 72 | 33 | $2,878 |
| Imiquimod Generic | 51 | 86 | 30 | $1,894 |
| Mupirocin Generic | 46 | 46 | 31 | $405 |
| Fluorouracil Generic | 41 | 41 | 37 | $2,563 |
Brand drugs: 286 claims; generic drugs: 1,688 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bernard N Robinowitz $3,434 ($3,434 in general payments such as food, travel and fees) from 17 companies. The largest payer was Pfizer Inc. with $460.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 31 | $460 |
| Abbvie Inc. ABBV | 21 | $432 |
| Janssen Biotech, Inc. JNJ | 16 | $408 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $350 |
| E.R. Squibb & Sons, L.L.C. BMY | 18 | $274 |
| Amgen Inc. AMGN | 15 | $273 |
| Arcutis Biotherapeutics, Inc. ARQT | 22 | $246 |
| UCB, Inc. UCB.BR | 23 | $227 |
| Galderma Laboratories, L.P. GALD.SW | 12 | $155 |
| LEO Pharma Inc. | 8 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.